Five-week-old female Syrian golden hamsters weighing approximately 80 g were purchased from Japan SLC, Inc. (Shizuoka, Japan). The hamsters were kept in cages on hardwood chip bedding (n = 3 hamsters/cage) and kept at 22 ± 2 °C and 55 ± 5% humidity. The animals were maintained under specific pathogen-free conditions with a 12 h light/dark cycle. The Quick Fat diet (crude fat, 13.6%; crude protein, 24.2%; total calories, 4.06 kcal/g) (CLEA Japan, Tokyo, Japan) was used as a high-fat regimen. Montelukast, bambuterol and levocetirizine were purchased from Tokyo Chemical Industry Co., Ltd. (Tokyo, Japan). BOP was obtained from Toronto Research Chemicals Inc. (Toronto, ON, Canada).
Levocetirizine
Manufactured by Tokyo Chemical Industry
Sourced in Japan
Levocetirizine is a chemical compound used in the production of laboratory equipment. It serves as a key component in various analytical and research applications.
Automatically generated - may contain errors
Lab products found in correlation
Montelukast, by Tokyo Chemical Industry (1 mentions)
Quick fat diet, by CLEA Japan (1 mentions)
Loratadine, by Tokyo Chemical Industry (1 mentions)
Pranlukast, by Cayman Chemical (1 mentions)
Promethazine, by Tokyo Chemical Industry (1 mentions)
Ketotifen, by Tokyo Chemical Industry (1 mentions)
Montelukast, by Cayman Chemical (1 mentions)
Tranilast, by Tokyo Chemical Industry (1 mentions)
Zafirlukast, by Cayman Chemical (1 mentions)
Fexofenadine, by Tokyo Chemical Industry (1 mentions)
Ebastine, by Tokyo Chemical Industry (1 mentions)
Amlexanox, by Tokyo Chemical Industry (1 mentions)
2 protocols using levocetirizine
1
Syrian Golden Hamster High-Fat Diet Model
2
Diverse Pharmacological Modulators of Inflammatory Pathways
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Montelukast, pranlukast and zafirlukast as leukotriene receptor antagonists were purchased from Cayman Chemical (Ann Arbor, MI, USA). Suplatast tosilate as a Th2 cytokine inhibitor, sodium cromoglicate, tranilast, amlexanox and pemirolast as mediator release inhibitors, ozagrel as a thromboxane A2 synthesis inhibitor, seratrodast as a thromboxane A 2 receptor antagonist, diphenhydramine as an ethanolamine H1 blocker, chlorpheniramine as a propylamine H1 blocker, cyproheptadine as a piperidine H1 blocker, promethazine as a phenothiazine H1 blocker, and ketotifen, fexofenadine, epinastine, cetirizine, levocetirizine, emedastine, loratadine, azelastine, mequitazine and ebastine as second-generation H1 receptor antagonists were purchased from Tokyo Chemical Industry (Tokyo, Japan).
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!